Clinical Trials Logo

Gastric Ulcer clinical trials

View clinical trials related to Gastric Ulcer.

Filter by:

NCT ID: NCT02759224 Completed - Gastric Ulcer Clinical Trials

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

Start date: April 15, 2016
Phase: Phase 1
Study type: Interventional

An Open-Label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics of BRI-1501 Tablet and Coadministration of Lafutidine and Irsogladine maleate as Individual Tablets in Healthy Adult Volunteers

NCT ID: NCT02423187 Completed - Gastric Ulcer Clinical Trials

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Start date: March 17, 2015
Phase:
Study type: Observational

To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.

NCT ID: NCT02219529 Completed - Chronic Gastritis Clinical Trials

Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases

MCE
Start date: August 2014
Phase: Phase 3
Study type: Interventional

A new Magnetic-controlled Capsule Endoscopy (MCE) was developed by ANKON and got SFDA's approval in China in 2013. It has recently been evaluated to compare the diagnostic accuracy of MCE with that of standard gastroscopy for gastric diseases in 70 patients with encouraging results (In Press). To further testify the diagnostic accuracy of MCE for both the diffuse and focal diseases in stomach, we performed this single-blinded multi-center prospective study compared MCE with gastroscopy in patients with gastric symptoms and indication for upper GI Endoscopy.

NCT ID: NCT01964131 Completed - Gastric Ulcer Clinical Trials

BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

Start date: October 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is; To investigate whether a D961H sachet 20 mg is bioequivalent to a D961H HPMC capsule 20 mg by the assessment of percentage of time with intragastric pH>4. To compare a D961H sachet 20 mg with a D961H HPMC capsule 20 mg by the assessment of percentage of time with intragastric pH>3 during 24 hours and 24-hour median pH. To compare PK properties of a D961H sachet 20 mg with those of D961H HPMC capsule 20 mg. To evaluate the safety and tolerability of a D961H sachet 20 mg and D961H HPMC capsule 20 mg.

NCT ID: NCT01762397 Completed - Gastritis Clinical Trials

A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers

Start date: December 2012
Phase: Phase 1
Study type: Interventional

The Purpose of a randomized, double-blind, placebo-controlled, single-dose, dose-escalation clinical trial is to explore investigate the safety, tolerability, pharmacokinetics, and food effect of PMK-S005 after oral administration in healthy male volunteers.

NCT ID: NCT01729182 Completed - Gastric Ulcer Clinical Trials

Nexium Capsules LDA Specific Clinical Experience Investigation

Start date: January 1, 2013
Phase:
Study type: Observational

The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or duodenal ulcer with Low dose Aspirin (LDA).

NCT ID: NCT01568398 Completed - Gastric Ulcer Clinical Trials

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

Start date: May 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to study the safety and efficacy of TAK-438, once daily (QD), in participants with a history of gastric or duodenal ulcer requiring long-term low-dose aspirin therapy will be investigated.

NCT ID: NCT01568385 Completed - Gastric Ulcer Clinical Trials

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to study the safety and efficacy of TAK-438, once daily (QD), in participants with a history of gastric or duodenal ulcer requiring long-term NSAID therapy will be investigated.

NCT ID: NCT01562600 Completed - Gastric Ulcer Clinical Trials

Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation

Start date: April 19, 2012
Phase:
Study type: Observational

The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or duodenal ulcer with non-steroidal anti-inflammatory drug (NSAID).

NCT ID: NCT01452711 Completed - Gastric Ulcer Clinical Trials

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer

Start date: November 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy of TAK-438, once daily (QD), compared to lansoprazole in patients with gastric ulcer.